Nisa Investment Advisors, LLC Denali Therapeutics Inc. Transaction History

Nisa Investment Advisors, LLC

$16.7 Billion
Q3 2024

A detailed history of Nisa Investment Advisors, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 66,482 shares of DNLI stock, worth $1.64 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

66,482

Previous 66,322 0.24%

Holding current value

$1.64 Million

Previous $1.54 Million 25.8%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$20.96 - $31.05 $3,353 - $4,968	160 Added 0.24%	66,482 $1.94 Million
Q2 2024 Jul 19, 2024	BUY	$14.96 - $23.22 $2,887 - $4,481	193 Added 0.29%	66,322 $1.54 Million
Q1 2024 May 01, 2024	BUY	$15.83 - $23.35 $1,108 - $1,634	70 Added 0.11%	66,129 $1.36 Million
Q4 2023 Jan 25, 2024	BUY	$16.2 - $23.18 $779,203 - $1.11 Million	48,099 Added 267.81%	66,059 $1.42 Million
Q3 2023 Nov 02, 2023	BUY	$20.63 - $30.17 $206 - $301	10 Added 0.06%	17,960 $370,000
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $4,487 - $6,328	192 Added 1.08%	17,950 $529,000
Q1 2023 May 02, 2023	SELL	$21.91 - $32.67 $3,505 - $5,227	-160 Reduced 0.89%	17,758 $409,000
Q3 2022 Nov 07, 2022	BUY	$25.97 - $38.53 $2,648 - $3,930	102 Added 0.57%	17,918 $544,000
Q2 2022 Aug 03, 2022	BUY	$20.88 - $35.19 $317,376 - $534,888	15,200 Added 581.04%	17,816 $524,000
Q1 2022 Apr 29, 2022	SELL	$29.0 - $47.27 $35,815 - $58,378	-1,235 Reduced 32.07%	2,616 $84,000
Q4 2021 Feb 03, 2022	SELL	$42.59 - $55.02 $97,744 - $126,270	-2,295 Reduced 37.34%	3,851 $132,000
Q3 2021 Oct 18, 2021	SELL	$48.48 - $78.23 $2,327 - $3,755	-48 Reduced 0.77%	6,146 $310,000
Q2 2021 Aug 06, 2021	SELL	$50.3 - $78.44 $5,030 - $7,844	-100 Reduced 1.59%	6,194 $486,000
Q1 2021 Apr 26, 2021	BUY	$53.8 - $81.53 $24,210 - $36,688	450 Added 7.7%	6,294 $359,000
Q4 2020 Jan 25, 2021	BUY	$36.89 - $93.56 $120,040 - $304,444	3,254 Added 125.64%	5,844 $489,000
Q3 2020 Oct 20, 2020	BUY	$23.13 - $38.84 $42,327 - $71,077	1,830 Added 240.79%	2,590 $93,000
Q2 2020 Jul 27, 2020	BUY	$16.01 - $28.82 $4,803 - $8,646	300 Added 65.22%	760 $18,000
Q1 2020 Apr 17, 2020	BUY	$14.2 - $27.98 $6,532 - $12,870	460 New	460 $8,000

Others Institutions Holding DNLI

# of Institutions

228

Shares Held

120M

Call Options Held

60.6K

Put Options Held

48.4K

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $3.31B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.

Account

Nisa Investment Advisors, LLC Denali Therapeutics Inc. Transaction History